Aaron Boudreau

Aaron Boudreau has a strong background in research and development within the biotechnology field. Aaron is currently working as the Senior Director of Target Biology at Scorpion Therapeutics, a position they have held since 2022. Before that, they worked at Calico Life Sciences as a Principal Scientist in Oncology from 2017 to 2022. Aaron'srole at Calico Life Sciences also included a previous position as Scientist II in Oncology from 2017 to 2020. Prior to their time at Calico Life Sciences, they worked as a Senior Scientific Researcher in Discovery Oncology at Genentech from 2013 to 2017. Aaron's extensive research experience began in 2010 when they served as a Postdoctoral Fellow at the University of California, San Francisco, where they developed innovative approaches to identify genes predicting long-term risk of recurrence and treatment response for breast cancer patients. Aaron also had research roles at Berkeley Lab as a Graduate Student Research Associate from 2004 to 2010 and at BIOVECTRA as an NSERC Undergraduate Student Research Assistant from 2003 to 2004. Aaron began their research career as an Undergraduate Student Researcher at Dalhousie University in 2003.

Aaron Boudreau earned a Bachelor's degree in Combined Honors (Biochemistry and Biology) from Dalhousie University in 2004. Aaron then went on to pursue a Doctor of Philosophy (PhD) in Comparative Biochemistry at the University of California, Berkeley from 2004 to 2010.